Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey
Open Access
- 21 June 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 119 (25), 5996-6004
- https://doi.org/10.1182/blood-2011-12-396028
Abstract
Data on the clinical spectrum and therapeutic management of noninfectious mixed cryoglobulinemia vasculitis (CryoVas) in the era of hepatitis C virus screening are lacking. We analyzed data from 242 patients with noninfectious mixed CryoVas included in the French multicenter CryoVas survey. Baseline manifestations were purpura (75%), peripheral neuropathy (52%), arthralgia or arthritis (44%), glomerulonephritis (35%), cutaneous ulcers (16%), and cutaneous necrosis (14%). A connective tissue disease was diagnosed in 30% and B-cell non-Hodgkin lymphoma in 22%, whereas the CryoVas was considered to be essential in 48%. With the use of Cox-marginal structural models, rituximab plus corticosteroids showed the greater therapeutic efficacy compared with corticosteroids alone and alkylating agents plus corticosteroids to achieve complete clinical, renal, and immunologic responses and a prednisone dosage < 10 mg/d at 6 months. However, this regimen was also associated with severe infections, particularly when high doses of corticosteroids were used, whereas death rates did not differ between the therapeutic regimens. The role of each of these strategies remains to be defined in well-designed randomized controlled trials.Keywords
This publication has 23 references indexed in Scilit:
- Prognostic factors in patients with hepatitis C virus infection and systemic vasculitisArthritis & Rheumatism, 2011
- Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registryArthritis Care & Research, 2010
- Detection of Occult Hepatitis C and Hepatitis B Virus Infections from Peripheral Blood Mononuclear CellsImmunological Investigations, 2010
- Occult hepatitis C: How convincing are the current data?Hepatology, 2008
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Occult Hepatitis C Virus Infection Revisited with Ultrasensitive Real-Time PCR AssayJournal of Clinical Microbiology, 2008
- CryoglobulinsJournal of Clinical Pathology, 2002
- CryoglobulinemiaMedicine, 2001
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritisKidney International, 1995